@kokofaceyoga's hormone therapy advice passes the safety test
Quick answer
The creator demonstrates intramuscular self-injection of testosterone, a procedure that is clinically appropriate for patients who have received proper training and hold a valid prescription, but which requires diagnosis of a hormonal condition, baseline labs, and ongoing monitoring. Testosterone use in women is exclusively off-label in the U.S., with clinical guidelines supporting only low-dose use for specific indications such as hypoactive sexual desire disorder in postmenopausal women. The video provides no clinical context, dose clarity, or indication, leaving viewers without the information needed to assess whether this applies to their own health situation.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @kokofaceyoga actually say?
The creator describes a weekly testosterone injection routine, explicitly stating "every Wednesday I do testosterone shot" and walking viewers through drawing up roughly 20 units (milliliters, presumably) from a vial, sterilizing the injection site, and self-injecting into the gluteal muscle. She mentions skipping estrogen but using testosterone, and stops short of showing the actual injection on camera.
To be clear about what this video is: it is a real-time demonstration of self-administered intramuscular testosterone, filmed and posted to a platform with millions of young viewers. The caption nods to medical supervision, but the content itself is a how-to walkthrough. That tension between the disclaimer and the demonstration is worth examining closely.
Does the science back this up?
Testosterone replacement therapy is a legitimate, FDA-approved treatment, and self-injection at home is clinically standard for patients who have been properly trained. The procedure itself, drawing from a vial and injecting intramuscularly into the gluteus, is textbook. The concern here is not whether TRT works. It does, when indicated.
The clinical evidence for TRT in women is actually more nuanced and contested than in men. A 2019 consensus statement by the Global Consensus Position Statement on the Use of Testosterone Therapy for Women (Wierman et al., published in the Journal of Clinical Endocrinology and Metabolism) found that low-dose testosterone has evidence for treating hypoactive sexual desire disorder in postmenopausal women, but noted that supraphysiologic dosing carries real risks including virilization, lipid changes, and cardiovascular effects. The "wellness optimization" framing that circulates on social media sits well outside what that consensus covers.
What did they get wrong (or right)?
Credit where it is due: sterilizing the vial top and injection site before drawing and injecting is correct practice. Not showing the actual injection to avoid platform violations suggests some awareness of content boundaries. Saying "consult a qualified medical professional" in the caption is the right message, even if the video content somewhat undercuts it.
What is missing matters more. The creator does not mention a diagnosis, a prescribing physician, or any indication for therapy. She does not clarify the concentration or actual dose of the testosterone she is drawing, describing it only as "20 millimeter, I guess," which is imprecise language that could genuinely confuse viewers about units. Intramuscular testosterone for women is dosed very differently than for men, and self-injection without proper training increases risk of nerve injury, infection, and injection-site reactions (Bhasin et al., 2010, New England Journal of Medicine). The casual framing of a medical procedure as a weekly wellness ritual normalizes hormone use without any clinical context.
What should you actually know?
Testosterone is a controlled substance in the United States and requires a prescription. It is not a supplement. Self-injection demonstrated casually on social media, without showing the prescription, the diagnosis, or the clinical supervision behind it, creates a misleading impression that this is something anyone can or should do at home on a schedule.
For women specifically, FDA-approved testosterone formulations do not exist in the U.S. as of 2024. Prescriptions are off-label. That does not make them wrong, but it means there is a real physician-patient relationship and ongoing monitoring that should be happening. Viewers who see this video and decide to source testosterone independently, or replicate the technique without training, face serious risks including infection, hormonal imbalance, and legal consequences.
The bottom line: what you are watching is a trained individual administering a prescribed medication, almost certainly under medical supervision we cannot verify from the video. What it looks like to an uncritical viewer is an invitation to try this themselves. Those are two very different things.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 4 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @kokofaceyoga's hormone therapy advice passes the safety test, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@kokofaceyoga's hormone therapy advice passes the safety test is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator demonstrates intramuscular self-injection of testosterone, a procedure that is clinically appropriate for patients who have received proper training and hold a valid prescription, but which requires diagnosis of a hormonal condition, baseline labs, and ongoing monitoring.
FormBlends verdict
The creator demonstrates intramuscular self-injection of testosterone, a procedure that is clinically appropriate for patients who have received proper training and hold a valid prescription, but which requires diagnosis of a hormonal condition, baseline labs, and ongoing monitoring. Testosterone use in women is exclusively off-label in the U.S., with clinical guidelines supporting only low-dose use for specific indications such as hypoactive sexual desire disorder in postmenopausal women. The video provides no clinical context, dose clarity, or indication, leaving viewers without the information needed to assess whether this applies to their own health situation.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator demonstrates intramuscular self-injection of testosterone, a procedure that is clinically appropriate for patients who have received proper training and hold a valid prescription, but which requires diagnosis of a hormonal condition, baseline labs, and ongoing monitoring. Testosterone use in women is exclusively off-label in the U.S., with clinical guidelines supporting only low-dose use for specific indications such as hypoactive sexual desire disorder in postmenopausal women. The video provides no clinical context, dose clarity, or indication, leaving viewers without the information needed to assess whether this applies to their own health situation.
- Testosterone is a Schedule III controlled substance in the U.S. and requires a prescription. No over-the-counter or supplement version exists.
- No FDA-approved testosterone formulation for women exists in the U.S. as of 2024. All female testosterone prescriptions are off-label, requiring a physician's clinical judgment.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Testosterone is a Schedule III controlled substance in the U.S. and requires a prescription. No over-the-counter or supplement version exists.
- No FDA-approved testosterone formulation for women exists in the U.S. as of 2024. All female testosterone prescriptions are off-label, requiring a physician's clinical judgment.
- The 2019 Global Consensus Position Statement (Wierman et al., Journal of Clinical Endocrinology and Metabolism) supports low-dose testosterone only for hypoactive sexual desire disorder in postmenopausal women, not general wellness optimization.
- "20 millimeter" is not a valid unit for injected volume. The correct unit is milliliters (mL). This kind of imprecision in a public demonstration of controlled substance injection can cause genuine dosing errors.
- Intramuscular self-injection without proper clinical training carries risks including nerve injury, hematoma, infection, and abscess formation (Bhasin et al., 2010, New England Journal of Medicine).
- A caption advising medical consultation does not offset video content that functionally demonstrates how to self-inject a controlled hormone. Platform audiences, particularly younger viewers, are more likely to absorb the demonstration than the disclaimer.
- Women using supraphysiologic testosterone doses face documented risks including virilization, changes in lipid profiles, and potential cardiovascular effects, all of which require ongoing lab monitoring that cannot be shown in a 60-second TikTok.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Koko Face Yoga · TikTok creator
6.3K views on this video
I take my health routines seriously and always prioritize safety. If you’re considering hormone therapy or any injections, please consult a qualified medical professional. Proper guidance matters. Yo
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Koko Face Yoga, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.